Proactive Investors - Run By Investors For Investors

Haydale Graphene selling 'commercial volumes' of ink for diabetes test in Taiwan

According to Haydale it is the first time graphene ink has been used in these quantities in the diabetes test market

Haydale Graphene Industries PLC’s  (LON:HAYD) Taiwanese operation HTW has started to ship commercial quantities of its graphene ink for diabetes test strips.

Trials have been underway for a year by the customer, but sizeable deliveries have now started as part of a 100Kg order.

READ: Haydale Graphene surges as University of Manchester graphene engineering centre joins fail-safe collaboration

According to Haydale it is the first time graphene ink has been used in these quantities in this market.

Trials have also started of an all-carbon sensor utilising graphene-enhanced ink that cuts out the currently used and expensive silver conductive ink tracks.

HTW’s inks are also scoring very well in a key printing metric, the C/V ratio, where a low percentage indicates a high consistent, repeatability factor.

The graphene inks have an accuracy rating of over 99%, which Haydale says is well above the industry norm.

David Banks, interim executive chairman, said:  "Our Taiwan facility is only 15 months old and, from a standing start, has now developed a range of functionalised graphene inks that are gaining market acceptance where repeat sales have pleasingly started to occur. 

"Over the last four months, HTW has supplied over 100Kg of inks to 12 print customers at various stages of evaluation."

View full HAYD profile View Profile

Haydale Graphene Industries PLC Timeline

Related Articles

Itaconix
May 24 2019
In May, Itaconix received its first purchase order from chemical firm Nouryon for its personal care polymer following the signing of an exclusive supply agreement in February
Graphene
February 18 2019
The firm specialises in using nanomaterials, including graphene, to improve or enhance the properties of products such as plastics or ceramics
Grape bunches
April 03 2019
Eden Research's first product Mevalone, a grape fungicide which is used to target the botrytis disease, is currently being sold throughout the southern EU zone and Kenya

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use